Delayed progression or regression of coronary atherosclerosis with intensive risk factor modification

Sports Medicine

Volumn 22, Issue 5, 1996, Pages 306-320

  Franklin, Barry A ^a   Kahn, Joel K ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIET; EXERCISE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; MOBILIZATION; REVIEW; RISK FACTOR; SECONDARY PREVENTION;

EID: 10544226571     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-199622050-00004     Document Type: Review

References (36)

1. Hubbard JD, Inkeles S, Barnard RJ. Nathan Pritikin's heart [letter]. N Engl J Med 1985; 313: 52
2. Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N Engl J Med 1985; 312: 805-11
3. Blankenhorn DH, Johnson RL, Mack WJ, et al. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990; 263: 1646-52
4. Roberts WC. Extreme hypercholesterolemia = malignant atherosclerosis. Am J Cardiol 1984; 54: 242-3
5. Roberts WC. Factors linking cholesterol to atherosclerotic plaques. Am J Cardiol 1988; 62: 495-9
6. Roberts WC. Atherosclerotic risk factors - are there ten or is there only one? Am J Cardiol 1989; 64: 552-4
7. Roberts WC. Lipid-lowering therapy after an atherosclerotic event. Am J Cardiol 1989; 64: 693-5
8. Vogel RA. Comparative clinical consequences of aggressive lipid management, coronary angioplasty and bypass surgery in coronary artery disease. Am J Cardiol 1992; 64: 1229-33
9. Levy RI, Brensike JF, Epstein SE, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 325-37
10. Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-40
11. Frick MH, Elo O, Haapa K, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-45
12. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-12
13. Brown G, Alberts JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-98
14. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy. The monitored atherosclerosis regression study (MARS). Ann Intern Med 1993; 119: 969-76
15. Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial. Circulation 1994; 89: 959-68
16. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9
17. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563-9
18. Hunninghake DB, Stein EA, Dujovne CA, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993; 328: 1213-9
19. Superko HR, Krauss RM. Coronary artery disease regression: Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994; 90: 1056-69
20. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990; 336: 129-33
21. Barnard ND, Scherwitz LW, Ornish D. Adherence and acceptability of a low-fat, vegetarian diet among patients with cardiac disease. J Cardiopulmonary Rehabil 1992; 12: 423-31
22. Ornish D. Can life-style changes reverse coronary atherosclerosis? Hosp Pract 1991; May 15: 123-32
23. Whitney EJ, Hantman RK, Ashcom TL, et al. Reversibility of fixed atherosclerotic lesions with aggressive risk factor modification. Mil Med 1991; 156: 422-9
24. Schuler G, Hambrecht R, Schlierf G, et al. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease. Circulation 1992; 86: 1-11
25. Hambrecht R, Niebauer J, Marburger C, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993; 22: 468-77
26. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-90
27. Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term intense risk factor modification. JAMA 1995; 274: 894-901
28. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-21
29. Brown BG, Zhao X-Q, Sacco DE, et al. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-91
30. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease? Circulation 1988; 78: 1157-66
31. Little WC, Gwinn NS, Burrows MT, et al. Cause of acute myocardial infarction late after successful coronary artery bypass grafting. Am J Cardiol 1990; 65: 808-10
32. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-7
33. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-93
34. Weintraub WS, Boccuzzi SJ, Klein L, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994; 331: 1331-7
35. Kahn JK. Reversing coronary atherosclerosis. Postgrad Med 1993; 94: 50-65
36. NCEP-II. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults: summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 1993; 269: 3015-23